date:May 23, 2013
chief executive officer, said in a statement.
For the fiscal year, net sales improved 0.9% to $2.61 billion, excluding sales from the 53rd week in 2012. Comps were down 0.5%, due to low inflation and a shift toward generic drugs. Net earnings of $27.4 million decreased 13.7%.
Eidson said Spartan was well-positioned to benefit from a gradually improving economy in Michigan, although the combination of the Easter sales shift, a continued shift to generic drugs and the cycling of a new store ope